CR845 (IV)

· Cara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CR845 (IV), covering 2020-07-29 to 2020-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus [Phase 2, Phase 3]